Wilson Martin — SEC Form 4 filings

SEC reporting owner CIK 1704342. 23 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2024-02-16 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ROCKET PHARMACEUTICALS, INC. (RCKT)General Counsel2319 legs · 128,168 sh · $705,82216

Form 4 filings — Wilson Martin

FiledFormIssuerReported transactionsSource
2026-09-154ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 75,364 @ $3.40EDGAR
2026-08-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 631 @ $3.38EDGAR
2026-08-174ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 3,493 @ $3.38EDGAR
2026-05-214ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 662 @ $3.01EDGAR
2026-05-144ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 3,361 @ $3.61EDGAR
2026-02-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 1,376 @ $3.34EDGAR
2026-02-184ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 12,253 @ $3.31EDGAR
2026-02-134ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 311,813 @ $0 · Grant/award (A): 468,187 (derivative) @ $0EDGAR
2025-11-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 1,646 @ $2.98EDGAR
2025-11-104ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 100,000 @ $0EDGAR
2025-09-094ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 150,000 @ $0EDGAR
2025-08-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 1,004 @ $3.06 · Sale (S): 588 @ $3.00EDGAR
2025-08-184ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 12,109 @ $3.02EDGAR
2025-05-224ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 587 @ $6.45EDGAR
2025-05-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 946 @ $6.53EDGAR
2025-02-254ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 3,222 @ $10.58EDGAR
2025-02-134ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 90,358 @ $0 · Grant/award (A): 134,642 (derivative) @ $0EDGAR
2024-11-254ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 1,175 @ $13.05EDGAR
2024-08-204ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 1,027 @ $18.50EDGAR
2024-05-204ROCKET PHARMACEUTICALS, INC. (RCKT)Option exercise (M): 2,420 @ $0 · Other (J): 28,763 @ $0 · Other (J): 16,947 @ $0 · Sale (S): 1,048 @ $23.35 · Option exercise (M): 2,420 (derivative) @ $0 · Other (J): 28,763 (derivative) @ $0 · +1 moreEDGAR
2024-03-044ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 4,100 @ $29.33EDGAR
2024-02-214ROCKET PHARMACEUTICALS, INC. (RCKT)Sale (S): 3,576 @ $29.84 · Grant/award (A): 16,644 @ $0 · Grant/award (A): 49,091 (derivative) @ $0EDGAR
2024-02-164ROCKET PHARMACEUTICALS, INC. (RCKT)Option exercise (M): 9,712 @ $0 · Option exercise (M): 9,712 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1704342 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →